Abstract
Certain types of glass vials used as primary containers for liquid formulations of biopharmaceutical drug products have been observed with glass flake like delamination or 'lamellae' under certain conditions during storage. The cause of this delamination is in part related to the glass surface defects, which renders the vials susceptible to flaking, and are formed during the high temperature melting and annealing used for vial fabrication and shaping. Current European Pharmacopoeia (Ph. Eur.) method to assess glass vial quality utilizes acid titration of vial extract pools to determine hydrolytic resistance or alkalinity. Four alternative techniques with improved throughput, convenience, and/or comprehension were examined by subjecting seven lots of vials to analysis by all techniques. The first three new techniques of conductivity, flame photometry, and inductively coupled plasma mass spectrometry (ICP-MS) measured the same sample pools as acid titration. All three showed good correlation with alkalinity; conductivity (R2=0.9951), flame photometry sodium (R2=0.9895), and several elements by ICP-MS [(sodium (R2=0.9869), boron (R2=0.9796), silicon (R2=0.9426), total (R2=0.9639)]. The fourth technique processed the vials under conditions that promote delamination, termed the Accelerated Lamellae Formation (ALF), and then inspected those vials visually for lamellae. The visual inspection results without the lot with different processing condition correlated well with alkalinity (R2=0.9474). Due to vial processing differences affecting alkalinity measurements and delamination propensity differently, ratio of silicon and sodium measurements from ICP-MS was the most informative technique to assess overall vial quality and vial propensity for lamellae formation. The other techniques of conductivity, flame photometry, and ALF condition may still be suitable for routine screening of vial lots produced under consistent processes.
- Received August 28, 2015.
- Accepted February 2, 2016.
- Copyright © 2016, Parenteral Drug Association
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.